2021 Update GINA - Global Initiative for Asthma Part II

Last month, EUFOREA dedicated a show to GINA 2021 Update (Global Initiative for Asthma) and got an incredible response with thousands of people watching that show. In this TV Breaking News Show, we want to spend a little more time looking at the 2021 GINA Update from a Middle Eastern perspective.
@who recognizes that asthma is of major public health importance. According to #WHO, it was estimated that more than 339 million people had Asthma globally and there were 417,918 deaths due to asthma at the global level in 2016. GINA is a Global Strategy for managing #asthma based on recent scientific literature by an international panel of experts on the #GINA science committee.
Join Dr. David Bull to learn more about Asthma management and prevention, different biologics treatment and how GINA 2021 can be implemented in real life given a large amount of novel information provided, as he interviews Professor Mona Al-Ahmad, Senior Consultant allergist and Clinical Immunology at Al-Rashed Allergy Centre Kuwait City, Kuwait.
You will also find out what are the biggest strengths and progresses made in GINA 2021 and an area of further improvement of GINA beyond 2021.
Stay in touch for further news from EUFOREA!
🌐 Visit our website: bit.ly/3qTanpG
➡️ Follow us on Facebook: bit.ly/3cnNyFF
➡️ Follow us on LinkedIn: bit.ly/2OqtWsf
➡️ Follow us on Twitter: bit.ly/38wrrM7
​
📌 EUFOREA is an international non-profit organization forming an alliance of all stakeholders dedicated to reduce the prevalence and burden of allergies and airway diseases through the implementation of optimal patient care through education, research and advocacy.
--------------------------------------------------------------------------------------------------------------------------
Subscribe to our UA-cam Channel for our latest videos within Allergies and Airway Diseases
bit.ly/3eMvc3E
--------------------------------------------------------------------------------------------------------------------------
Get in touch with EUFOREA team for any questions
bit.ly/2OtlIQp
#EUFOREA